Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Cardiovascular and Circulatory System - Congestive Heart Failure Drug Pipeline Report

Published by: Life Science Analytics (LSA)

Published: Jun. 22, 2007 - 14 Pages


Table of Contents


RECENT HIGHLIGHTS AND CHANGES
Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Congestive Heart Failure Pipeline Overview
% of Projects (By Phase of Development)
No. of Projects by Phase of Development
Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
Company Overview - Pipeline Projects
Legend
Top 20 companies in late stage Congestive Heart Failure Projects
Top 20 companies in early stage Congestive Heart Failure Projects
Full Pipeline View
Pre Clinical Pipeline View
Phase I Pipeline View
Phase II Pipeline View

Abstract

Life Science Analytics', ""Cardiovascular and Circulatory System - Congestive Heart Failure Drug Pipeline Report"" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of congestive heart failure drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits
  • Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008